Martin Shkreli violated lifetime pharmaceutical ban: FTC
Former drug company executive Martin Shkreli and his lead attorney Benjamin Brafman arrive at U.S. District Court for…
Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial
Eli Lilly on Wednesday said its experimental combination regimen showed greater weight loss than a high dose of…
Ozempic counterfeit ring charges against Indian nationals unsealed
Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…
Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug race
Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images Novartis‘ failure in a…
Trump strikes new drug pricing deals with nine midsized drugmakers
U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White…
Moderna, Merck cancer vaccine shows initial late-stage melanoma data
An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial,…
MMR vaccine: Trump wants to split childhood shot up
President Donald Trump‘s latest executive order calls for splitting the measles, mumps and rubella, or MMR, vaccine into…
AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…
Cyclospora: CDC says outbreak is in nine states
A customer shops for cilantro at a Walmart Supercenter on July 23, 2026, in Austin, Texas. Brandon Bell…
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
Trump’s generic drug tariffs: What it means for patients, drugmakers and prices
President Donald Trump‘s proposed tariffs on imported generic medicines have raised fresh questions about whether low-cost drugmakers can…
What to know about testosterone replacement therapy
US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on…